RGBP

$0.00+0.00%visit website

Regen BioPharma Inc

Market Cap

$251,292

Finnhub, as of 2026-09-22

Sector

Health Care

Industry

Pharmaceutical Preparations

Beta (raw)

-0.28

60mo monthly vs SPY

P/E (TTM)

—

Price / TTM diluted EPS

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

—

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Sep 30, 2025	Q1 FY2026 Dec 31, 2025	Q2 FY2026 Mar 31, 2026	Q3 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	59	59	59	59	237
Research & development	12	210	2	0	224
Total operating expenses	182	611	213	35	1,040
Operating income	(123)	(552)	(154)	25	(804)
Interest expense	86	27	27	30	170
Pretax income	(572)	(968)	992	(638)	(1,186)
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(572)	(968)	992	(638)	(1,186)
EPS (basic) ($)		(0.01)	0.00	0.00	—
EPS (diluted) ($)		(0.01)	0.00	0.00	—
Weighted avg. shares (basic)		99,610	184,943	615,556
Weighted avg. shares (diluted)		99,610	184,943	615,556

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 17, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 49 more quarters, back to Mar 2013, with Tormere Pro.

Corporate Events (8-K)

1 filing in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Nov 2, 2026 accepted 6:08 AM ET	1.01Material agreement	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

—

of daily vol

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

No Form 4 transactions on record.

Gov Contracts

Agency	Amount	Awarded
Department of Energy	$35.3B	1978-09-30
Department of Energy	$20.2B	2005-06-01
Department of Energy	$18.0B	1999-10-27
Department of Health and Human Services	$974M	2017-09-30